🌊 Negócios em Emersão  ·  Vamos Emergir?  ·  Cadastre-se e ganhe 50 REC de bônus
Notícias

Acompanhe as Notícias da Recifes

Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.

131 notícias encontradas para "administration"
Rubio vows to end International Criminal Court "threat", claiming it interferes with US op
Rubio vows to end International Criminal Court "threat", claiming it interferes with US op
A major diplomatic battle is shaping up between Washington and its closest allies over the future of global justice. The Trump administration is preparing to completely isolate the International Criminal Court. But the move is already drawing fierce resistance from both the Unite
FDA approves oral Utebzi antibiotic for complicated urinary tract infections
The U.S. Food and Drug Administration has approved GSK's Utebzi (tebipenem pivoxil), an oral antibiotic, for the treatment of complicated urinary tract infections (cUTIs).
Youth tobacco use falls, but flavored e-cigarettes are still a concern
The U.S. Food and Drug Administration (FDA) this week shared findings from the 2025 National Youth Tobacco Survey (NYTS). The American Heart Association has issued the following statement:
Eye-tracking technology helps researchers see IV pump safety through student nurses' eyes
Eye-tracking technology helps researchers see IV pump safety through student nurses' eyes
Researchers at the University of Massachusetts Amherst are using eye-tracking technology to help understand how nurses interact with intravenous smart pumps, providing a new way to identify design flaws in systems associated with more medication errors than any other route of adm
Foto: Maksim Goncharenok / Pexels
Same day administration of COVID-19 and influenza vaccines not associated with increase in
A target trial emulation found that same-day coadministration of the COVID-19 and influenza vaccines was not associated with a higher risk of serious or clinically meaningful adverse events compared with receiving only an influenza vaccine. Across multiple updated COVID-19 vaccin
Foto: Pixabay / Pexels
From caffeine to 'healthy' labeling, FDA sets year-end agenda for US food supply
The U.S. Food and Drug Administration (FDA) has announced the food supply issues it seeks to tackle by year's end. O recorte ajuda a contextualizar a pauta dentro de Fitness.
FDA scientists warn against expanded peptide access as Kennedy reshapes advisory panel
FDA scientists warn against expanded peptide access as Kennedy reshapes advisory panel
Federal health scientists are urging caution about expanding access to controversial peptide drugs, even as the U.S. Food and Drug Administration (FDA) reshapes the advisory panel that will consider whether to loosen those restrictions.
FDA lets 20 ZYN nicotine pouches claim lower risk than cigarettes; critics warn of danger
The U.S. Food and Drug Administration (FDA) has authorized marketing of 20 ZYN nicotine pouch products as a lower-risk option than cigarettes, a decision that drew immediate criticism from anti-cancer advocates worried about youth use.
FDA approves Tzield for children with new stage 3 type 1 diabetes
The U.S. Food and Drug Administration has granted accelerated approval to Sanofi's Tzield (teplizumab-mzwv) to delay the decline in endogenous insulin production in children aged 8 to 17 years recently diagnosed with stage 3 type 1 diabetes.
Aid for brain-bleed recovery receives expedited review
A noninvasive neuromodulation technology has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for reducing a dangerous narrowing of blood vessels in the brain that can follow a brain bleed from a ruptured aneurysm.
FDA approves first treatment for thyroid eye disease
The U.S. Food and Drug Administration has approved Lumvoa (veligrotug-vvze) for the treatment of thyroid eye disease (TED). Approval was granted to Viridian Therapeutics.
Gene clues reveal why some rare leukemia patients resist tagraxofusp therapy
Researchers at The University of Texas MD Anderson Cancer Center have identified why some patients with a rare type of leukemia, called blastic plasmacytoid dendritic cell neoplasm (BPDCN), eventually develop resistance to tagraxofusp, the first Food and Drug Administration-appro